Results 251 to 260 of about 70,417 (342)

A Kampo medicine, choreito, evaluated on female lower urinary tract symptoms (LUTS) with bladder pain

Traditional &Kampo Medicine, EarlyView.
Abstract Aim Choreito (CRT) is a pharmaceutical‐grade Kampo medicine and has been widely prescribed for patients with lower urinary tract symptoms (LUTS) and cystitis in Japan. The purpose of this study was to investigate the efficacy and safety of CRT in patients with persisting bladder pain.
Mineo Takei, Yohei Tokita, Marie Hamaguchi, Manami Aishima, Sachiko Ichikura, Ayami Okabe, Seiji Naito, Akira Yokomizo   +7 more
wiley   +1 more source

Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips. [PDF]

Cannabis
Smith GL.
europepmc   +1 more source

Effects of Sacha Inchi (Plukenetia volubilis L.) Oil Supplementation on Hyperglycaemia, Hypertension and Hyperlipidaemia (3Hs) Patients: A Preliminary Human Trial. [PDF]

Plant Foods Hum Nutr
Mhd Rodzi NAR, Mohd Sopian M, Lee LK.
europepmc   +1 more source

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

PROTEOMICS, EarlyView.
Paul Perco, Matthias Ley, Kinga Kęska‐Izworska, Dorota Wojenska, Enrico Bono, Samuel M. Walter, Lucas Fillinger, Klaus Kratochwill   +7 more
wiley   +1 more source

Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China. [PDF]

Front Cardiovasc Med
Xu Y, Ma J, Yang Y, Liu L, Zhao X, Wang Y, Mijiti A, Cheng Q, Ma J.   +8 more
europepmc   +1 more source

The Charlson Comorbidity Index Predicts Clinically Relevant Postoperative Pancreatic Fistula in Patients Undergoing Distal Pancreatectomy Not Pancreaticoduodenectomy

World Journal of Surgery, EarlyView.
ABSTRACT Background Postoperative pancreatic fistula (POPF) is a severe complication after pancreatectomy. The preoperative prediction of POPF would benefit patients by providing postoperative management tailored to each patient based on the risk for POPF.
Hiroki Imamura, Yoshito Tomimaru, Shogo Kobayashi, Kazuki Sasaki, Shinichiro Hasegawa, Daisaku Yamada, Hirofumi Akita, Takehiro Noda, Hidenori Takahashi, Yuichiro Doki, Hidetoshi Eguchi   +10 more
wiley   +1 more source

In the Beginning, Lipoproteins Cross the Endothelial Barrier. [PDF]

J Atheroscler Thromb
Goldberg IJ, Cabodevilla AG, Younis W.
europepmc   +1 more source

Healthcare dashboard technologies and data visualization for lipid management: A scoping review. [PDF]

BMC Med Inform Decis Mak
Samadbeik M, Engstrom T, Lobo EH, Kostner K, Austin JA, Pole JD, Sullivan C.   +6 more
europepmc   +1 more source

Prevalence, Awareness, and Factors Associated with Hypertension Among People Living with HIV in Eastern Uganda. A Multicentre Cross-Sectional Study. [PDF]

HIV AIDS (Auckl)
Kanyike AM, Nakawuki AW, Akech GM, Kihumuro RB, Kintu TM, Nalunkuma R, Nakandi RM, Mugabi J, Twijukye N, Bwayo D, Katuramu R.   +10 more
europepmc   +1 more source

Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO‐1, PSO‐4, and LTE trials

The Journal of Dermatology, EarlyView.
Abstract Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, was effective and well tolerated at a dose of 6 mg once daily through 1 year (52 weeks) in patients with moderate to severe plaque psoriasis in the phase 3 POETYK PSO‐1 and POETYK PSO‐4 trials.
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Yukari Okubo, Katsuyoshi Habiro, Katsuki Tsuritani, Subhashis Banerjee, Kim Hoyt, Renata M. Kisa, Mamitaro Ohtsuki   +9 more
wiley   +1 more source